TY - JOUR
T1 - Trajectories of metabolic parameters after bilateral oophorectomy in premenopausal women
AU - Kapoor, Ekta
AU - Faubion, Stephanie S.
AU - Gazzuola Rocca, Liliana
AU - Mielke, Michelle M.
AU - Smith, Carin Y.
AU - Rocca, Walter A.
N1 - Funding Information:
Ekta Kapoor is a consultant for Mithra Pharmaceuticals, Astellas Pharmaceuticals and Womaness. Michelle M. Mielke receives funding from the National Institutes of Health and unrestricted research grants from Biogen, and she consults for Brain Protection Company. Walter A. Rocca receives funding from the National Institutes of Health.
Funding Information:
The Mayo Clinic Cohort Study of Oophorectomy and Aging (MOA-2) is partly supported by the National Institute on Aging (NIA grant U54 AG044170 ) and uses the resources of the Rochester Epidemiology Project (REP) medical records-linkage system, which is supported by the National Institute on Aging (NIA grant AG 058738 ), by the Mayo Clinic Research Committee, and by fees paid annually by REP users. However, the content of this article is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health (NIH) or of the Mayo Clinic. Walter A. Rocca was partly funded by the Ralph S. and Beverley E. Caulkins Professorship of Neurodegenerative Diseases Research of the Mayo Clinic.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/11
Y1 - 2022/11
N2 - Objective: To study the trajectories of metabolic parameters after bilateral oophorectomy. Study design: This population-based cohort study included a random sample of all premenopausal women who underwent bilateral oophorectomy at or before age 45 years from 1988 to 2007 in Olmsted County, Minnesota, and their age-matched (±1 year) referent women who did not undergo bilateral oophorectomy. Main outcome measures: The medical records of all women were reviewed to collect the metabolic parameters over a 10-year period. We compared three groups of women: 1) referent women (n = 270), 2) women who underwent bilateral oophorectomy and received estrogen therapy (n = 163), and 3) women who underwent bilateral oophorectomy and did not receive estrogen therapy (n = 107). Results: Over 10 years of follow-up, the three groups had significantly different mean values of diastolic blood pressure, weight, body mass index (BMI), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C). However, women with and without bilateral oophorectomy were already different at baseline for hyperlipidemia, systolic blood pressure, weight, and BMI. Nevertheless, the trajectories of change over 10 years were significant for weight (group by time interaction p = 0.03), BMI (p = 0.03), and HDL-C (p = 0.004). The changes occurred primarily in the initial 4–5 years. Women who received estrogen therapy after bilateral oophorectomy were comparable to the referent women with respect to the weight and BMI trends, and they experienced an increase in HDL-C over time. Conclusion: Women who underwent bilateral oophorectomy before menopause experienced unfavorable changes in some metabolic parameters possibly increasing their cardiovascular risk.
AB - Objective: To study the trajectories of metabolic parameters after bilateral oophorectomy. Study design: This population-based cohort study included a random sample of all premenopausal women who underwent bilateral oophorectomy at or before age 45 years from 1988 to 2007 in Olmsted County, Minnesota, and their age-matched (±1 year) referent women who did not undergo bilateral oophorectomy. Main outcome measures: The medical records of all women were reviewed to collect the metabolic parameters over a 10-year period. We compared three groups of women: 1) referent women (n = 270), 2) women who underwent bilateral oophorectomy and received estrogen therapy (n = 163), and 3) women who underwent bilateral oophorectomy and did not receive estrogen therapy (n = 107). Results: Over 10 years of follow-up, the three groups had significantly different mean values of diastolic blood pressure, weight, body mass index (BMI), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C). However, women with and without bilateral oophorectomy were already different at baseline for hyperlipidemia, systolic blood pressure, weight, and BMI. Nevertheless, the trajectories of change over 10 years were significant for weight (group by time interaction p = 0.03), BMI (p = 0.03), and HDL-C (p = 0.004). The changes occurred primarily in the initial 4–5 years. Women who received estrogen therapy after bilateral oophorectomy were comparable to the referent women with respect to the weight and BMI trends, and they experienced an increase in HDL-C over time. Conclusion: Women who underwent bilateral oophorectomy before menopause experienced unfavorable changes in some metabolic parameters possibly increasing their cardiovascular risk.
KW - Bilateral oophorectomy
KW - Blood pressure
KW - Estrogen therapy
KW - Lipid profile
KW - Menopause
KW - Weight
UR - http://www.scopus.com/inward/record.url?scp=85134849358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134849358&partnerID=8YFLogxK
U2 - 10.1016/j.maturitas.2022.07.005
DO - 10.1016/j.maturitas.2022.07.005
M3 - Article
C2 - 35905571
AN - SCOPUS:85134849358
SN - 0378-5122
VL - 165
SP - 38
EP - 46
JO - Maturitas
JF - Maturitas
ER -